FDA Warns Medtronic Use in Patients Under Age 18
Medtronic Infuse Bone Graft substitutes containing recombinant proteins or synthetic peptides In a safety alert issued Jan. 21, the U.S. Food and Drug Administration (FDA) warned that bone graft substitutes containing recombinant proteins or synthetic peptides, such as Medtronic Infuse, should not be used in patients younger than 18. … [Read more...] about FDA Warns Medtronic Use in Patients Under Age 18
Medtronic Infuse Cancer Side Effects Lawsuit
Medtronic Infuse Cancer Side Effects. Research has indicated that there may be a strong association with Medtronic Inc.'s Infuse Bone Graft product, and cancer, specifically: Prostate Cancer Breast Cancer Pancreatic Cancer Recently, reports have also raised questions about Medtronic's handling of clinical … [Read more...] about Medtronic Infuse Cancer Side Effects Lawsuit
Medtronic Infuse Recipients Receive $8.45 Million in Settlements
The University of California, Los Angeles has agreed to pay a combined $8.45 million to two patients who received Medtronic's controversial Infuse bone graft product. These individuals filed lawsuits alleging that the product caused unwanted bone growth. They also claimed that the implanting surgeon had a conflict of interest because … [Read more...] about Medtronic Infuse Recipients Receive $8.45 Million in Settlements
Medtronic Utilizes Preemption Defense in Medtronic Infuse Case
US supreme court denied the case of medtronic. US supreme court denied the case of medtronic.The denial of review by the United States Supreme Court today in the case of Caplinger v. Medtronic, Inc., Docket No. 15-321, though it might appear to be a victory for medical device manufacturer, Medtronic, Inc., it was not. While a shallow … [Read more...] about Medtronic Utilizes Preemption Defense in Medtronic Infuse Case
Medtronic Claims InFuse Injury Suits Preempted by Federal Law
In an effort to avert lawsuits filed over injuries attributed to its InFuse bone growth device, device maker, Medtronic Inc., has tried to convince courts that the federal preemption clause of the federal Food, Drug and Cosmetic Act preempts the lawsuits. Recently, a split 10th Circuit Court of Appeals rejected the plaintiff’s … [Read more...] about Medtronic Claims InFuse Injury Suits Preempted by Federal Law
Three Medtronic Infuse Personal Injury Cases Remanded to Circuit Court
Three lawsuits filed against Medtronic, Inc. over injuries associated with its Infuse bone graft device will be remanded to the Circuit Court of the City of St. Louis for further proceedings, according to the law firms Parker Waichman LLP, Neblett Beard & Arsenault, and The Drakulich Firm, which are collaborating on the … [Read more...] about Three Medtronic Infuse Personal Injury Cases Remanded to Circuit Court
Louisiana Man Files Medtronic Infuse Lawsuit
Medtronic Infuse May Cause Unwanted Bone Growth In The Spine. The lawsuit, filed in U.S. District Court for the Eastern District of Louisiana, alleges the use of Infuse in a transforaminal lumber interbody fusion resulted in painful, unwanted bone growth along the plaintiff's spine. As we've reported previously, it's … [Read more...] about Louisiana Man Files Medtronic Infuse Lawsuit
Medtronic Infuse Associated with Higher Rate of Cancers than First Believed
Higher Rate of Cancers Noted In Lawsuits. Dr. Eugene Carragee, a Stanford University School of Medicine professor and editor of The Spine Journal. has raised more questions about Medtronic Inc.'s Infuse bone growth product. According to Carragee, Infuse may be more strongly associated with cancer than previously thought. In June, … [Read more...] about Medtronic Infuse Associated with Higher Rate of Cancers than First Believed
Medtronic Infuse Disclosures Put Medical Journals in Spotlight
Some medical journals are facing fire again over their conflicts-of-interest policies in the wake of the latest Medtronic Infuse scandal. The latest Medtronic Infuse controversy indicates that many prestigious medical journals aren't doing enough to spot obvious financial bias. Last week, The Spine Journal published an entire … [Read more...] about Medtronic Infuse Disclosures Put Medical Journals in Spotlight
Journal Questions Integrity of Medtronic Infuse Studies
Medtronic influenced what it characterizes as misleading and biased Infuse studies. A major medical journal is slamming studies for Medtronic Inc.'s Infuse Bone Graft product, asserting that information regarding side effects was omitted from final published articles. The Spine Journal questions whether researchers’ financial … [Read more...] about Journal Questions Integrity of Medtronic Infuse Studies
Surgeon in Medtronic Infuse Study Scandal Resigns
Timothy R. Kuklo, the former Army surgeon who has been accused of falsifying data in a study of Medtronic Inc.'s Infuse Bone Graft, has resigned from his post at Washington University Medical School, according to The New York Times. As we’ve reported previously, the study, which Kuklo conducted during his tenure at Walter Reed … [Read more...] about Surgeon in Medtronic Infuse Study Scandal Resigns
Medtronic Recalls Specific Pacemaker Models Due to Issues
Medtronic could be facing more trouble over Infuse Bone Graft. Medtronic could be facing more trouble over its Infuse Bone Graft product. According to a report on the website "Finance and Commerce", a Texas woman is preparing to file a lawsuit that blames off-label use of Infuse for injuries she suffered after cervical spine … [Read more...] about Medtronic Recalls Specific Pacemaker Models Due to Issues
